GSTM1 and chronic myelogenous leukemia, BCR-ABL1 positive: Similar results with our findings were clearly described regarding increased risk of CML for the GSTM1/null genotype by Bhat et al. (2012), Lordelo et al. (2012) and Al‐Achkar et al. (2014).